Company intelligence
Northway Biotech
Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania
About Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support
Verified activity
Signals from Northway Biotech
4 published signals
Presence & Recognition
Northway Biotech is hosting a visit to its Gene Therapy Center in Vilnius during the Erdvėlaivis Žemė science festival in September 10-17, 2026.
Reported by Northway Biotech
Operations & Supply
Northway Biotech is close to its Waltham site.
Reported by Brooke Williams
Presence & Recognition
Northway Biotech is attending the BPI 2026 conference in Boston at Booth EAST 631.
Reported by Northway Biotech
Operations & Supply
Northway Biotech kicked off the grand opening of its new Innovative Cell Therapy and Personalized Medicine Center in Vilnius, the first center of its kind in the Baltic States, built in just over a year with a €61 million investment.
Reported by Northway Biotech